Pfizer Expands Cancer Platform With High-Priced Medivation Acquisition
August 22, 2016 at 12:59 PM EDT
Despite the high price paid, we don't expect any major changes in Pfizer's fair value estimate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.